F.D.A. Is Lax on Oversight During Trials, Inquiry Finds  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Resources for Food and Drug Administration (FDA)

F.D.A. Is Lax on Oversight During Trials, Inquiry Finds

www.nytimes.com

The Food and Drug Administration does almost nothing to police the financial conflicts of doctors who conduct clinical trials of drugs and medical devices in human subjects, government investigators are reporting. Moreover, the investigators say, agency officials told them that trying to protect patients from such conflicts was not worth the effort. In 42 percent of clinical trials, the agency did not receive forms disclosing doctors’ financial conflicts and did nothing about the problem, according to the investigation, which was conducted by the inspector general of the Department of Health and Human Services and whose results were scheduled to be made public Monday.

View the Resource



Share or bookmarklet this web page at:





Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2009 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.